Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Methods Mol Biol ; 2497: 333-337, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35771455

RESUMO

Intracellular reactive oxygen species (ROS) act as an important signaling transductor in cells, regulating almost every aspect of cell biology. Measurements of ROS production thus, offer links between oxidative stress and cell pathophysiology. Here, we describe a simple screening assay in intact adherent cells by fluorescence microplate readers, using dihydroethidium (DHE) and MitoSOX to measure cytosolic superoxide and mitochondrial superoxide production, respectively. This assay enables a quick and reliable assessment of ROS generation in a well-controlled environment.


Assuntos
Estresse Oxidativo , Espécies Reativas de Oxigênio , Superóxidos , Etídio/análogos & derivados , Fenantridinas , Espécies Reativas de Oxigênio/análise , Superóxidos/análise
2.
Trends Cell Biol ; 32(5): 391-405, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-34836781

RESUMO

Mitochondria generate the energy to sustain cell viability and serve as a hub for cell signalling. Their own genome (mtDNA) encodes genes critical for oxidative phosphorylation. Mutations of mtDNA cause major disease and disability with a wide range of presentations and severity. We review here an emerging body of data suggesting that changes in cell metabolism and signalling pathways in response to the presence of mtDNA mutations play a key role in shaping disease presentation and progression. Understanding the impact of mtDNA mutations on cellular energy homeostasis and signalling pathways seems fundamental to identify novel therapeutic interventions with the potential to improve the prognosis for patients with primary mitochondrial disease.


Assuntos
DNA Mitocondrial , Doenças Mitocondriais , DNA Mitocondrial/genética , DNA Mitocondrial/metabolismo , Humanos , Mitocôndrias/genética , Mitocôndrias/metabolismo , Doenças Mitocondriais/genética , Mutação/genética , Fosforilação Oxidativa
3.
Nat Commun ; 12(1): 6409, 2021 11 04.
Artigo em Inglês | MEDLINE | ID: mdl-34737295

RESUMO

Mutations of the mitochondrial genome (mtDNA) cause a range of profoundly debilitating clinical conditions for which treatment options are very limited. Most mtDNA diseases show heteroplasmy - tissues express both wild-type and mutant mtDNA. While the level of heteroplasmy broadly correlates with disease severity, the relationships between specific mtDNA mutations, heteroplasmy, disease phenotype and severity are poorly understood. We have carried out extensive bioenergetic, metabolomic and RNAseq studies on heteroplasmic patient-derived cells carrying the most prevalent disease related mtDNA mutation, the m.3243 A > G. These studies reveal that the mutation promotes changes in metabolites which are associated with the upregulation of the PI3K-Akt-mTORC1 axis in patient-derived cells and tissues. Remarkably, pharmacological inhibition of PI3K, Akt, or mTORC1 reduced mtDNA mutant load and partially rescued cellular bioenergetic function. The PI3K-Akt-mTORC1 axis thus represents a potential therapeutic target that may benefit people suffering from the consequences of the m.3243 A > G mutation.


Assuntos
DNA Mitocondrial/metabolismo , Alvo Mecanístico do Complexo 1 de Rapamicina/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , DNA Mitocondrial/genética , Feminino , Humanos , Alvo Mecanístico do Complexo 1 de Rapamicina/genética , Mutação/genética , Fosfatidilinositol 3-Quinases/genética , Proteínas Proto-Oncogênicas c-akt/genética
4.
Sci Rep ; 9(1): 2896, 2019 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-30814608

RESUMO

Avian coccidiosis is an economically important disease in the poultry industry. In view of the disadvantages of anti-coccidial drugs in chickens, edible plants and their compounds are re-emerging as an alternative strategy to combat this disease. A previous publication reported that the edible plant B. pilosa showed promise for use against coccidiosis. Here, we first investigated into the anti-coccidial effects of B. pilosa. We found that B. pilosa at 100 ppm or more significantly suppressed E. tenella as evidenced by reduction in mortality rate, oocyst excretion and gut pathological severity in chickens and its minimum prophylactic duration was 3 days. Next, we explored the mode of action of anti-coccidial mechanism of B. pilosa. The E. tenella oocysts were not directly killed by B. pilosa; however, administration of the plant suppressed oocyst sporulation, sporozoite invasion, and schizonts in the life cycle of E. tenella. Besides, B. pilosa boosted T cell-mediated immunity. Finally, we characterized the related anti-coccidial phytochemicals and their mode of action. One of three potent polyynes present in B. pilsoa, Compound 1 (cytopiloyne), acted against coccidiosis in chickens in a similar manner to B. pilosa. These data illustrate the anti-coccidial potency and mechanism of B. pilosa and one of its active compounds, and provide a cornerstone for development of novel herbal remedies for avian coccidiosis.


Assuntos
Bidens/química , Galinhas/imunologia , Coccidiose/tratamento farmacológico , Coccidiose/veterinária , Eimeria tenella/efeitos dos fármacos , Extratos Vegetais/farmacologia , Doenças das Aves Domésticas/prevenção & controle , Animais , Galinhas/crescimento & desenvolvimento , Galinhas/parasitologia , Coccidiose/parasitologia , Eimeria tenella/imunologia , Feminino , Oocistos/efeitos dos fármacos , Doenças das Aves Domésticas/parasitologia
5.
Sci Rep ; 7: 46336, 2017 04 12.
Artigo em Inglês | MEDLINE | ID: mdl-28402317

RESUMO

Successful treatments against bacterial infections depend on antimicrobial susceptibility testing (AST). However, conventional AST requires more than 24 h to obtain an outcome, thereby contributing to high patient mortality. An antibiotic therapy based on experiences is therefore necessary for saving lives and escalating the emergence of multidrug-resistant pathogens. Accordingly, a fast and effective drug screen is necessary for the appropriate administration of antibiotics. The mixed pathogenic nature of infectious diseases emphasizes the need to develop an assay system for polymicrobial infections. On this basis, we present a novel technique for simultaneous and quantitative monitoring of co-cultured microorganisms by coupling optical diffusometry with bead-based immunoassays. This simple integration simultaneously achieves a rapid AST analysis for two pathogens. Triple color particles were simultaneously recorded and subsequently analyzed by functionalizing different fluorescent color particles with dissimilar pathogen-specific antibodies. Results suggested that the effect of the antibiotic, gentamicin, on co-cultured Pseudomonas aeruginosa and Staphylococcus aureus was effectively distinguished by the proposed technique. This study revealed a multiplexed and time-saving (within 2 h) platform with a small sample volume (~0.5 µL) and a low initial bacterial count (50 CFU per droplet, ~105 CFU/mL) for continuously monitoring the growth of co-cultured microorganisms. This technique provides insights into timely therapies against polymicrobial diseases in the near future.


Assuntos
Antibacterianos/farmacologia , Testes de Sensibilidade Microbiana/métodos , Pseudomonas aeruginosa/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Técnicas de Cocultura , Humanos , Imunoensaio/instrumentação , Imunoensaio/métodos , Imunoensaio/normas , Testes de Sensibilidade Microbiana/instrumentação , Testes de Sensibilidade Microbiana/normas , Pseudomonas aeruginosa/crescimento & desenvolvimento , Sensibilidade e Especificidade , Staphylococcus aureus/crescimento & desenvolvimento
6.
Data Brief ; 7: 995-998, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27761492

RESUMO

Cytopiloyne (CP), a novel polyacetylene compound extracted from B. pilosa, shows a multi-bioactivity, including immunomodulatory and antidiabetes. Here, we investigated the anti-Listeria effect of cytopiloyne in mice by assessing mortality, clearance of L. monocytogenes, and pathology examination. The data presented herein are supplemental to our research article entitled "Cytopiloyne, a polyacetylenic glucoside from Bidens pilosa, acts as a novel anticandidial agent via regulation of macrophages" [1].

7.
J Ethnopharmacol ; 184: 72-80, 2016 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-26924565

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Bidens pilosa, a tropical and sub-tropical herbal plant, is used as an ethnomedicine for bacterial infection or immune modulation in Asia, America and Africa. It has been demonstrated that cytopiloyne (CP), a bioactive polyacetylenic glucoside purified from B. pilosa, increases the percentage of macrophages in the spleen but the specific effects on macrophages remain unclear. AIM OF THE STUDY: The aim of this study was to evaluate the effects of CP on macrophage activity and host defense in BALB/c mice with Candida parapsilosis infection and investigate the likely mechanisms. MATERIALS AND METHODS: RAW264.7 cells, a mouse macrophage cell line, were used to assess the effects of CP on macrophage activity by phagocytosis assay, colony forming assay and acridine orange/crystal violet stain. To evaluate the activity of CP against C. parapsilosis, BALB/c mouse infection models were treated with/without CP and histopathological examination was performed. The role of macrophages in the infection model was clarified by treatment with carrageenan, a selective macrophage-toxic agent. RAW264.7 macrophage activities influenced by CP were further investigated by lysosome staining, phagosomal acidification assay, lysosome enzyme activity and PKC inhibitor GF109203X. RESULTS: The results showed that CP in vitro enhances the ability of RAW264.7 macrophages to engulf and clear C. parapsilosis. In the mouse model, CP treatment improved the survival rate of Candida-infected mice and lowered the severity of microscopic lesions in livers and spleens via a macrophage-dependent mechanism. Furthermore, with CP treatment, the fusion and acidification of phagolysosomes were accelerated and the lysosome enzyme activity of RAW264.7 macrophages was elevated. PKC inhibitor GF109203X reversed the increase in phagocytic activity by CP demonstrating that the PKC pathway is involved in the macrophage-mediated phagocytosis of C. parapsilosis. CONCLUSIONS: Our data suggested that CP, as an immunomodulator, enhances macrophage activity against C. parapsilosis infections.


Assuntos
Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Candidíase/tratamento farmacológico , Glucosídeos/farmacologia , Glucosídeos/uso terapêutico , Macrófagos/efeitos dos fármacos , Poli-Inos/farmacologia , Poli-Inos/uso terapêutico , Animais , Bidens , Candidíase/metabolismo , Candidíase/microbiologia , Candidíase/patologia , Carragenina/farmacologia , Linhagem Celular , Feminino , Fígado/efeitos dos fármacos , Fígado/microbiologia , Fígado/patologia , Lisossomos/metabolismo , Macrófagos/fisiologia , Camundongos Endogâmicos BALB C , Fagocitose/efeitos dos fármacos , Fitoterapia , Proteína Quinase C/metabolismo , Baço/efeitos dos fármacos , Baço/microbiologia , Baço/patologia
8.
PLoS One ; 11(2): e0148864, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26863001

RESUMO

This study combined optical diffusometry and bead-based immunoassays to develop a novel technique for quantifying the growth of specific microorganisms and achieving rapid AST. Diffusivity rises when live bacteria attach to particles, resulting in additional energy from motile microorganisms. However, when UV-sterilized (dead) bacteria attach to particles, diffusivity declines. The experimental data are consistent with the theoretical model predicted according to the equivalent volume diameter. Using this diffusometric platform, the susceptibility of Pseudomonas aeruginosa to the antibiotic gentamicin was tested. The result suggests that the proliferation of bacteria is effectively controlled by gentamicin. This study demonstrated a sensitive (one bacterium on single particles) and time-saving (within 2 h) platform with a small sample volume (~0.5 µL) and a low initial bacteria count (50 CFU per droplet ~ 105 CFU/mL) for quantifying the growth of microorganisms depending on Brownian motion. The technique can be applied further to other bacterial strains and increase the success of treatments against infectious diseases in the near future.


Assuntos
Antibacterianos/farmacologia , Gentamicinas/farmacologia , Imunoensaio/métodos , Testes de Sensibilidade Microbiana/métodos , Pseudomonas aeruginosa/efeitos dos fármacos , Carga Bacteriana , Divisão Celular , Resistência a Medicamentos , Microscopia Eletrônica de Varredura , Microscopia de Fluorescência , Microesferas , Movimento (Física) , Tamanho da Partícula , Pseudomonas aeruginosa/crescimento & desenvolvimento , Pseudomonas aeruginosa/fisiologia , Difusão Térmica , Fatores de Tempo , Viscosidade
9.
PLoS One ; 11(1): e0146141, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26765226

RESUMO

In the interests of food safety and public health, plants and their compounds are now re-emerging as an alternative approach to treat gastrointestinal diseases in chickens. Here, we studied the impact of the edible medicinal plant, B. pilosa, on growth performance, gut bacteria and coccidiosis in chickens. First, we found that B. pilosa significantly elevated body weight gain and lowered feed conversion ratio in chickens. Next, we showed that B. pilosa reduced cecal damage as evidenced by increased hemorrhage, villus destruction and decreased villus-to-crypt ratio in chicken ceca. We also performed pyrosequencing of the PCR ampilcons based on the 16S rRNA genes of gut bacteria in chickens. Metagenomic analysis indicated that the chicken gut bacteria belonged to 6 phyla, 6 classes, 6 orders, 9 families, and 8 genera. More importantly, we found that B. pilosa affected the composition of bacteria. This change in bacteria composition was correlated with body weight gain, feed conversion ratio and gut pathology in chickens. Collectively, this work suggests that B. pilosa has beneficial effects on growth performance and protozoan infection in chickens probably via modulation of gut bacteria.


Assuntos
Ração Animal , Bidens , Coccidiose/veterinária , Microbioma Gastrointestinal , Doenças das Aves Domésticas/parasitologia , Aumento de Peso , Animais , Biodiversidade , Galinhas , Análise por Conglomerados
10.
J Vet Sci ; 13(3): 245-52, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23000581

RESUMO

The incidence of diabetes mellitus is increasing among companion animals. This disease has similar characteristics in both humans and animals. Diabetes is frequently identified as an independent risk factor for infections associated with increased mortality. In the present study, homozygous diabetic (db/db) mice were infected with Listeria (L.) monocytogenes and then treated with the anti-diabetic drug exendin-4, a glucagon-like peptide 1 analogue. In aged db/db mice, decreased CD11b(+) macrophage populations with higher lipid content and lower phagocytic activity were observed. Exendin-4 lowered high lipid levels and enhanced phagocytosis in macrophages from db/db mice infected with L. monocytogenes. Exendin-4 also ameliorated obesity and hyperglycemia, and improved ex vivo bacteria clearance by macrophages in the animals. Liver histology examined during L. monocytogenes infection indicated that abscess formation was much milder in exendin-4-treated db/db mice than in the control animals. Moreover, mechanistic studies demonstrated that expression of ATP binding cassette transporter 1, a sterol transporter, was higher in macrophages isolated from the exendin-4-treated db/db mice. Overall, our results suggest that exendin-4 decreases the risk of infection in diabetic animals by modifying the interaction between intracellular lipids and phagocytic macrophages.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Metabolismo dos Lipídeos , Listeria monocytogenes/efeitos dos fármacos , Listeriose/tratamento farmacológico , Macrófagos/metabolismo , Peptídeos/uso terapêutico , Peçonhas/uso terapêutico , Transportador 1 de Cassete de Ligação de ATP , Transportadores de Cassetes de Ligação de ATP/metabolismo , Fatores Etários , Animais , Análise Química do Sangue , Colesterol/metabolismo , Diabetes Mellitus Tipo 2/genética , Dislipidemias/tratamento farmacológico , Dislipidemias/genética , Exenatida , Feminino , Hiperglicemia/tratamento farmacológico , Hiperglicemia/genética , Injeções Intraperitoneais , Metabolismo dos Lipídeos/efeitos dos fármacos , Listeria monocytogenes/imunologia , Listeriose/imunologia , Listeriose/microbiologia , Macrófagos/efeitos dos fármacos , Camundongos , Obesidade/tratamento farmacológico , Obesidade/genética , Fagocitose/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA